β-catenin mediates monocrotaline-induced pulmonary hypertension via glycolysis in rats
Metabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension (PH). However, the regulatory mechanisms of glycolysis in macrophages are still elusive. Cumulative evidence indicates that β-catenin plays a crucial ro...
Saved in:
Published in | BMC cardiovascular disorders Vol. 24; no. 1; pp. 381 - 14 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
23.07.2024
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Metabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension (PH). However, the regulatory mechanisms of glycolysis in macrophages are still elusive. Cumulative evidence indicates that β-catenin plays a crucial role in metabolic reprogramming. This study aimed to investigate the effect of β-catenin on macrophage glycolysis in PH.
LPS-induced BMDMs were generated via in vitro experiments. A monocrotaline (MCT)-induced PH rat model was established, and the β-catenin inhibitor XAV939 was administered in vivo. The role of β-catenin in glycolysis was analysed. The degree of pulmonary vascular remodelling was measured.
β-catenin was significantly increased in both in vitro and in vivo models. In LPS-induced BMDMs, β-catenin increased the levels of hexokinase 2 (HK2), phosphofructokinase (PFK), M2-pyruvate kinase (PKM2), lactate dehydrogenase (LDH), and lactate (LA) and the expression of inflammatory cytokines and promoted PASMC proliferation and migration in vitro. XAV939 decreased the level of glycolysis and downregulated the expression of inflammatory cytokines in vivo. MCT promoted pulmonary arterial structural remodelling and right ventricular hypertrophy, and XAV939 alleviated these changes.
Our findings suggest that β-catenin is involved in the development of PH by promoting glycolysis and the inflammatory response in macrophages. Inhibition of β-catenin could improve the progression of PH. |
---|---|
AbstractList | Metabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension (PH). However, the regulatory mechanisms of glycolysis in macrophages are still elusive. Cumulative evidence indicates that β-catenin plays a crucial role in metabolic reprogramming. This study aimed to investigate the effect of β-catenin on macrophage glycolysis in PH.
LPS-induced BMDMs were generated via in vitro experiments. A monocrotaline (MCT)-induced PH rat model was established, and the β-catenin inhibitor XAV939 was administered in vivo. The role of β-catenin in glycolysis was analysed. The degree of pulmonary vascular remodelling was measured.
β-catenin was significantly increased in both in vitro and in vivo models. In LPS-induced BMDMs, β-catenin increased the levels of hexokinase 2 (HK2), phosphofructokinase (PFK), M2-pyruvate kinase (PKM2), lactate dehydrogenase (LDH), and lactate (LA) and the expression of inflammatory cytokines and promoted PASMC proliferation and migration in vitro. XAV939 decreased the level of glycolysis and downregulated the expression of inflammatory cytokines in vivo. MCT promoted pulmonary arterial structural remodelling and right ventricular hypertrophy, and XAV939 alleviated these changes.
Our findings suggest that β-catenin is involved in the development of PH by promoting glycolysis and the inflammatory response in macrophages. Inhibition of β-catenin could improve the progression of PH. BackgroundMetabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension (PH). However, the regulatory mechanisms of glycolysis in macrophages are still elusive. Cumulative evidence indicates that β-catenin plays a crucial role in metabolic reprogramming. This study aimed to investigate the effect of β-catenin on macrophage glycolysis in PH.MethodsLPS-induced BMDMs were generated via in vitro experiments. A monocrotaline (MCT)-induced PH rat model was established, and the β-catenin inhibitor XAV939 was administered in vivo. The role of β-catenin in glycolysis was analysed. The degree of pulmonary vascular remodelling was measured.Resultsβ-catenin was significantly increased in both in vitro and in vivo models. In LPS-induced BMDMs, β-catenin increased the levels of hexokinase 2 (HK2), phosphofructokinase (PFK), M2-pyruvate kinase (PKM2), lactate dehydrogenase (LDH), and lactate (LA) and the expression of inflammatory cytokines and promoted PASMC proliferation and migration in vitro. XAV939 decreased the level of glycolysis and downregulated the expression of inflammatory cytokines in vivo. MCT promoted pulmonary arterial structural remodelling and right ventricular hypertrophy, and XAV939 alleviated these changes.ConclusionsOur findings suggest that β-catenin is involved in the development of PH by promoting glycolysis and the inflammatory response in macrophages. Inhibition of β-catenin could improve the progression of PH. Abstract Background Metabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension (PH). However, the regulatory mechanisms of glycolysis in macrophages are still elusive. Cumulative evidence indicates that β-catenin plays a crucial role in metabolic reprogramming. This study aimed to investigate the effect of β-catenin on macrophage glycolysis in PH. Methods LPS-induced BMDMs were generated via in vitro experiments. A monocrotaline (MCT)-induced PH rat model was established, and the β-catenin inhibitor XAV939 was administered in vivo. The role of β-catenin in glycolysis was analysed. The degree of pulmonary vascular remodelling was measured. Results β-catenin was significantly increased in both in vitro and in vivo models. In LPS-induced BMDMs, β-catenin increased the levels of hexokinase 2 (HK2), phosphofructokinase (PFK), M2-pyruvate kinase (PKM2), lactate dehydrogenase (LDH), and lactate (LA) and the expression of inflammatory cytokines and promoted PASMC proliferation and migration in vitro. XAV939 decreased the level of glycolysis and downregulated the expression of inflammatory cytokines in vivo. MCT promoted pulmonary arterial structural remodelling and right ventricular hypertrophy, and XAV939 alleviated these changes. Conclusions Our findings suggest that β-catenin is involved in the development of PH by promoting glycolysis and the inflammatory response in macrophages. Inhibition of β-catenin could improve the progression of PH. Metabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension (PH). However, the regulatory mechanisms of glycolysis in macrophages are still elusive. Cumulative evidence indicates that β-catenin plays a crucial role in metabolic reprogramming. This study aimed to investigate the effect of β-catenin on macrophage glycolysis in PH.BACKGROUNDMetabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension (PH). However, the regulatory mechanisms of glycolysis in macrophages are still elusive. Cumulative evidence indicates that β-catenin plays a crucial role in metabolic reprogramming. This study aimed to investigate the effect of β-catenin on macrophage glycolysis in PH.LPS-induced BMDMs were generated via in vitro experiments. A monocrotaline (MCT)-induced PH rat model was established, and the β-catenin inhibitor XAV939 was administered in vivo. The role of β-catenin in glycolysis was analysed. The degree of pulmonary vascular remodelling was measured.METHODSLPS-induced BMDMs were generated via in vitro experiments. A monocrotaline (MCT)-induced PH rat model was established, and the β-catenin inhibitor XAV939 was administered in vivo. The role of β-catenin in glycolysis was analysed. The degree of pulmonary vascular remodelling was measured.β-catenin was significantly increased in both in vitro and in vivo models. In LPS-induced BMDMs, β-catenin increased the levels of hexokinase 2 (HK2), phosphofructokinase (PFK), M2-pyruvate kinase (PKM2), lactate dehydrogenase (LDH), and lactate (LA) and the expression of inflammatory cytokines and promoted PASMC proliferation and migration in vitro. XAV939 decreased the level of glycolysis and downregulated the expression of inflammatory cytokines in vivo. MCT promoted pulmonary arterial structural remodelling and right ventricular hypertrophy, and XAV939 alleviated these changes.RESULTSβ-catenin was significantly increased in both in vitro and in vivo models. In LPS-induced BMDMs, β-catenin increased the levels of hexokinase 2 (HK2), phosphofructokinase (PFK), M2-pyruvate kinase (PKM2), lactate dehydrogenase (LDH), and lactate (LA) and the expression of inflammatory cytokines and promoted PASMC proliferation and migration in vitro. XAV939 decreased the level of glycolysis and downregulated the expression of inflammatory cytokines in vivo. MCT promoted pulmonary arterial structural remodelling and right ventricular hypertrophy, and XAV939 alleviated these changes.Our findings suggest that β-catenin is involved in the development of PH by promoting glycolysis and the inflammatory response in macrophages. Inhibition of β-catenin could improve the progression of PH.CONCLUSIONSOur findings suggest that β-catenin is involved in the development of PH by promoting glycolysis and the inflammatory response in macrophages. Inhibition of β-catenin could improve the progression of PH. |
ArticleNumber | 381 |
Author | Lan, Wei‑Fang Liao, Juan Wu, Dan-dan Chen, Xing Deng, Yan Meng, Hui Li, Li-xiang |
Author_xml | – sequence: 1 givenname: Hui surname: Meng fullname: Meng, Hui – sequence: 2 givenname: Yan orcidid: 0000-0003-3727-6986 surname: Deng fullname: Deng, Yan – sequence: 3 givenname: Juan surname: Liao fullname: Liao, Juan – sequence: 4 givenname: Dan-dan surname: Wu fullname: Wu, Dan-dan – sequence: 5 givenname: Li-xiang surname: Li fullname: Li, Li-xiang – sequence: 6 givenname: Xing surname: Chen fullname: Chen, Xing – sequence: 7 givenname: Wei‑Fang surname: Lan fullname: Lan, Wei‑Fang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39044140$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstuFDEQRS0URB7wAyxQS2zYNPjVfqwQinhEisQmEkur2nZPPPLYg90dafJZfAjfhJlJUJIFK5dc9x6VXfcUHaWcPEKvCX5PiBIfKqFK0h5T3mOOMe5vn6ETwiXpKRXk6EF9jE5rXWNMpML6BTpmGnNOOD5BP37_6i3MPoXUbbwLrazdJqdsS54hhuT7kNxiveu2S2wNKLvuerf1pXlqyKm7CdCt4s7muKuhdo1TYK4v0fMJYvWv7s4zdPXl89X5t_7y-9eL80-XveVazv00SM8knsB5pck0TRiPhDirhlHZUbBxpN6LiQ_UAbN2oNpxBhQs04MQkp2hiwPWZVibbQmbNp_JEMz-IpeVgTIHG70ZhbbKSiCyMRxV4KyjI6GjdpRZEI318cDaLmP7CuvTXCA-gj7upHBtVvnGEEIFZ5o1wrs7Qsk_F19nswnV-hgh-bxUw7DimGGphyZ9-0S6zktJ7auaSrfFarl_3puHI_2b5X5_TaAOgrauWoufjA0zzG0vbcIQDcHmb1TMISqmRcXso2Jum5U-sd7T_2P6AxazxKE |
CitedBy_id | crossref_primary_10_3389_fcvm_2025_1554702 |
Cites_doi | 10.1515/revneuro-2017-0032 10.1161/CIRCULATIONAHA.117.029930 10.1186/s13046-020-01808-3 10.3390/cancers11070904 10.1038/s41467-019-11662-3 10.1016/j.molimm.2020.02.017 10.3389/fphar.2019.00128 10.1016/j.immuni.2021.04.001 10.1186/s12929-018-0418-4 10.1186/s13046-021-02229-6 10.1111/imr.12608 10.1161/CIRCULATIONAHA.117.029254 10.1038/emboj.2012.150 10.1007/s11239-020-02356-5 10.15252/embj.201488598 10.1186/s13046-018-0673-y 10.1073/pnas.1821401116 10.1136/thoraxjnl-2016-209753 10.1136/bmj.j5492 10.1016/j.cell.2017.05.016 10.1038/s41392-021-00762-6 10.1152/ajplung.00260.2003 10.1038/s41598-022-06848-7 10.3389/fimmu.2023.1152881 10.1183/13993003.01913-2018 10.3892/mmr.2021.11833 10.1111/febs.15327 10.1186/s13287-022-02836-w 10.1161/CIRCULATIONAHA.117.028034 10.1016/j.chest.2017.10.007 10.1016/S2213-2600(15)00543-3 10.1536/ihj.19-096 10.1172/JCI120847 10.1016/j.imbio.2023.152345 |
ContentType | Journal Article |
Copyright | 2024. The Author(s). 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: 2024. The Author(s). – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12872-024-04000-z |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals (ODIN) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2261 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_b69c8c7a179d4d28adcd2b12b9d23ca6 PMC11264393 39044140 10_1186_s12872_024_04000_z |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Beijing China China |
GeographicLocations_xml | – name: China – name: Beijing China |
GrantInformation_xml | – fundername: Guangxi medical "139" Program for Training High-level Backbone Talents grantid: G201903053 – fundername: the Precision Medicine Foundation of Guangxi Key Laboratory of Cardio-cerebrovascular Disease grantid: GXXNXG202001 – fundername: the National Natural Science Foundation of China grantid: 82060051 – fundername: the projects of Guangxi Medical and Health Appropriate Technology Development and Promotion Application grantid: S2020030 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS ECGQY EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c497t-f57e370fade891fff00b11dc85b8cb63bb2ee6f452da3cc529d43a2ac3956673 |
IEDL.DBID | M48 |
ISSN | 1471-2261 |
IngestDate | Wed Aug 27 01:27:13 EDT 2025 Thu Aug 21 18:32:53 EDT 2025 Fri Jul 11 11:06:06 EDT 2025 Sat Jul 26 02:43:44 EDT 2025 Mon Jul 21 05:39:34 EDT 2025 Thu Apr 24 23:10:59 EDT 2025 Tue Jul 01 02:38:11 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Glycolysis β-catenin Macrophages NLRP3 inflammasome Monocrotaline Pulmonary hypertension |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c497t-f57e370fade891fff00b11dc85b8cb63bb2ee6f452da3cc529d43a2ac3956673 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-3727-6986 |
OpenAccessLink | https://www.proquest.com/docview/3091289767?pq-origsite=%requestingapplication% |
PMID | 39044140 |
PQID | 3091289767 |
PQPubID | 44077 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b69c8c7a179d4d28adcd2b12b9d23ca6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11264393 proquest_miscellaneous_3084030795 proquest_journals_3091289767 pubmed_primary_39044140 crossref_citationtrail_10_1186_s12872_024_04000_z crossref_primary_10_1186_s12872_024_04000_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-07-23 |
PublicationDateYYYYMMDD | 2024-07-23 |
PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC cardiovascular disorders |
PublicationTitleAlternate | BMC Cardiovasc Disord |
PublicationYear | 2024 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | S Dong (4000_CR34) 2022; 41 MK Culley (4000_CR26) 2018; 128 SJ Dumas (4000_CR7) 2018; 137 S-S Xie (4000_CR11) 2022; 12 T Valenta (4000_CR16) 2012; 31 F-Y Zhao (4000_CR22) 2021; 23 J Weatherald (4000_CR1) 2018; 137 B Zhu (4000_CR33) 2021; 54 Q Fan (4000_CR14) 2018; 37 A Vallée (4000_CR17) 2017; 29 G Simonneau (4000_CR2) 2019; 53 MM Hughes (4000_CR27) 2018; 281 M-Q Zhang (4000_CR9) 2023; 14 T Kondo (4000_CR4) 2019; 81 Y Fang (4000_CR29) 2019; 10 T Thenappan (4000_CR5) 2018; 360 G Soto-Heredero (4000_CR8) 2020; 287 D Wu (4000_CR12) 2023; 228 L Huang (4000_CR24) 2020; 121 J Liu (4000_CR28) 2022; 7 Y Jiang (4000_CR30) 2021; 40 R Nusse (4000_CR13) 2017; 169 MM Hoeper (4000_CR3) 2016; 4 P Caruso (4000_CR25) 2017; 136 HA Baarsma (4000_CR32) 2017; 72 Y Cao (4000_CR6) 2019; 116 Y Deng (4000_CR10) 2019; 10 L Deng (4000_CR15) 2022; 13 S El-Sahli (4000_CR18) 2019; 11 NS Hill (4000_CR19) 2017; 152 4000_CR35 W Feng (4000_CR20) 2020; 61 M Zeng (4000_CR21) 2021; 52 4000_CR31 C Lombry (4000_CR23) 2004; 286 |
References_xml | – volume: 29 start-page: 71 year: 2017 ident: 4000_CR17 publication-title: Rev Neurosci doi: 10.1515/revneuro-2017-0032 – volume: 137 start-page: 2371 year: 2018 ident: 4000_CR7 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.029930 – volume: 40 start-page: 13 year: 2021 ident: 4000_CR30 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-01808-3 – volume: 11 start-page: 904 year: 2019 ident: 4000_CR18 publication-title: Cancers doi: 10.3390/cancers11070904 – volume: 10 start-page: 3981 year: 2019 ident: 4000_CR29 publication-title: Nat Commun doi: 10.1038/s41467-019-11662-3 – volume: 121 start-page: 186 year: 2020 ident: 4000_CR24 publication-title: Mol Immunol doi: 10.1016/j.molimm.2020.02.017 – volume: 10 start-page: 128 year: 2019 ident: 4000_CR10 publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00128 – volume: 54 start-page: 1200 year: 2021 ident: 4000_CR33 publication-title: Immunity doi: 10.1016/j.immuni.2021.04.001 – ident: 4000_CR35 doi: 10.1186/s12929-018-0418-4 – volume: 41 start-page: 15 year: 2022 ident: 4000_CR34 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-021-02229-6 – volume: 281 start-page: 88 year: 2018 ident: 4000_CR27 publication-title: Immunol Rev doi: 10.1111/imr.12608 – volume: 137 start-page: 693 year: 2018 ident: 4000_CR1 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.029254 – volume: 31 start-page: 2714 year: 2012 ident: 4000_CR16 publication-title: EMBO J doi: 10.1038/emboj.2012.150 – volume: 52 start-page: 454 year: 2021 ident: 4000_CR21 publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-020-02356-5 – ident: 4000_CR31 doi: 10.15252/embj.201488598 – volume: 37 start-page: 9 year: 2018 ident: 4000_CR14 publication-title: J Exp Clin Cancer Res CR doi: 10.1186/s13046-018-0673-y – volume: 116 start-page: 13394 year: 2019 ident: 4000_CR6 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1821401116 – volume: 72 start-page: 746 year: 2017 ident: 4000_CR32 publication-title: Thorax doi: 10.1136/thoraxjnl-2016-209753 – volume: 360 start-page: j5492 year: 2018 ident: 4000_CR5 publication-title: BMJ doi: 10.1136/bmj.j5492 – volume: 169 start-page: 985 year: 2017 ident: 4000_CR13 publication-title: Cell doi: 10.1016/j.cell.2017.05.016 – volume: 81 start-page: 19 year: 2019 ident: 4000_CR4 publication-title: Nagoya J Med Sci – volume: 7 start-page: 3 year: 2022 ident: 4000_CR28 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00762-6 – volume: 286 start-page: L1002 year: 2004 ident: 4000_CR23 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00260.2003 – volume: 12 start-page: 3056 year: 2022 ident: 4000_CR11 publication-title: Sci Rep doi: 10.1038/s41598-022-06848-7 – volume: 14 start-page: 1152881 year: 2023 ident: 4000_CR9 publication-title: Front Immunol doi: 10.3389/fimmu.2023.1152881 – volume: 53 start-page: 1801913 year: 2019 ident: 4000_CR2 publication-title: Eur Respir J doi: 10.1183/13993003.01913-2018 – volume: 23 start-page: 39 year: 2021 ident: 4000_CR22 publication-title: Mol Med Rep doi: 10.3892/mmr.2021.11833 – volume: 287 start-page: 3350 year: 2020 ident: 4000_CR8 publication-title: FEBS J doi: 10.1111/febs.15327 – volume: 13 start-page: 162 year: 2022 ident: 4000_CR15 publication-title: Stem Cell Res Ther doi: 10.1186/s13287-022-02836-w – volume: 136 start-page: 2451 year: 2017 ident: 4000_CR25 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.028034 – volume: 152 start-page: 1106 year: 2017 ident: 4000_CR19 publication-title: Chest doi: 10.1016/j.chest.2017.10.007 – volume: 4 start-page: 306 year: 2016 ident: 4000_CR3 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(15)00543-3 – volume: 61 start-page: 160 year: 2020 ident: 4000_CR20 publication-title: Int Heart J doi: 10.1536/ihj.19-096 – volume: 128 start-page: 3704 year: 2018 ident: 4000_CR26 publication-title: J Clin Invest doi: 10.1172/JCI120847 – volume: 228 start-page: 152345 year: 2023 ident: 4000_CR12 publication-title: Immunobiology doi: 10.1016/j.imbio.2023.152345 |
SSID | ssj0017809 |
Score | 2.358012 |
Snippet | Metabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension (PH).... BackgroundMetabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary hypertension... Abstract Background Metabolic abnormalities and immune inflammation are deeply involved in pulmonary vascular remodelling and the development of pulmonary... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 381 |
SubjectTerms | Animals beta Catenin - metabolism Bone marrow Cell Movement - drug effects Cell Proliferation - drug effects Cytokines Disease Models, Animal Enzymes Glycolysis Glycolysis - drug effects Heart Hemodynamics Hexokinase Hypertension Hypertension, Pulmonary - chemically induced Hypertension, Pulmonary - metabolism Hypertension, Pulmonary - physiopathology Hypertrophy Hypertrophy, Right Ventricular - chemically induced Hypertrophy, Right Ventricular - metabolism Hypertrophy, Right Ventricular - physiopathology Inflammation Inflammation Mediators - metabolism L-Lactate dehydrogenase Laboratory animals Lactic acid Leukocyte migration Lipopolysaccharides Lungs Macrophages Macrophages - drug effects Macrophages - metabolism Male Metabolism Monocrotaline Myocytes, Smooth Muscle - drug effects Myocytes, Smooth Muscle - metabolism Myocytes, Smooth Muscle - pathology NLRP3 inflammasome Ostomy Phosphofructokinase Pulmonary arteries Pulmonary Artery - drug effects Pulmonary Artery - metabolism Pulmonary Artery - pathology Pulmonary Artery - physiopathology Pulmonary hypertension Pyruvate kinase Pyruvic acid Rats Rats, Sprague-Dawley Signal Transduction Smooth muscle Vascular Remodeling - drug effects Veins & arteries β-Catenin |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHhCXikcpKQUZqbfKamIntnMERFUhlVNRe7P8bFdaeat9ILU_ix_Cb2LsZFddhOiFa-wkzsw3npnY_gbgSFhnu-ACjQzV0DrR0V4FRYWL6A24N778hzz_Js6-t1-vuqsHpb7ynrCBHngQ3IkVvVNOGgSObz1TxjvPbMNs7xl3ppBto89bJ1Pj-oFUdb8-IqPEyQJnYcko-iOaQVvT-y03VNj6_xZi_rlT8oHrOX0Ou2PMSD4OY30BT0J6CU_Px1XxV3D56yfNG5vSJJFyEgTDR4LwmuG7M8FhChQzb9ShJ7erKTaY-R25wQR0XravzxL5MTHkenqHoMgEJQSfg8BY7MHF6ZeLz2d0LJhAXdvLJY2dDFzW0fig-ibGWNe2abxTnVXOCm4tC0HEtmPecOc6hiLlhhnHMUsSkr-GnTRL4Q0QiZI1EUObXJxY2ahazHSCMqhLNFjbVNCsxafdSCaea1pMdUkqlNCDyDWKXBeR6_sKjjf33A5UGv_s_SlrZdMz02CXCwgOPYJDPwaOCg7XOtWjbS40R7hgmimFrODDphmtKi-VmBRmq9wHE1-c_vqugv0BApuR8L7GGLKtK1Bb4Nga6nZLmtwU5u58XgsjQH7wPz7uLTxjBdGSMn4IO8v5KrzDCGlp3xdj-A1P4BJi priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwELagSIgX1HKGtihIvCGriZ34eEKAqCqk8lTEvlk-25VWznYPpPZn8UP4TYy93sAi1NfYcSYzn-fwMYPQW2as6b31OBAQQ2dZj6XwAjMbwBpQp11ehzz_ys6-dV8m_aQsuC3LscqtTsyK2g02rZGfUDBsEBxwxt_Pr3GqGpV2V0sJjfvoQUpdllDNJ2PA1XLRyO1FGcFOljAAJxisEk7QbfDtjjHKOfv_52j-e17yLwN0uo8eF8-x_rAR9QG65-MT9PC87I0_Rd9__cTpeFOcxjrfBwEnsgaqB_h2SnMYPYb4GyTp6vl6Bg16cVNfQRi6yIfYh1j_mOr6cnYD0EhpSmoYB-CxfIYuTj9ffDrDpWwCtp3kKxx67ilvgnZeyDaE0DSmbZ0VvRHWMGoM8Z6FridOU2t7Il1HNdGWQqzEOH2O9uIQ_UtUc6uZDuDgpBLFwgTRQbzjhQaJwrQ1bYXaLfuULSnFU2WLmcqhhWBqw3IFLFeZ5eq2Qu_Gd-abhBp39v6YpDL2TMmw84NhcanK3FKGSSss16BbXOeI0M46YlpipCMUfqFCR1uZqjJDl-oPnir0ZmyGuZU2THT0wzr1gfAXlKDsK_RiA4GREiob8CS7pkJiBxw7pO62xOlVzt-dbm2BH0hf3U3XIXpEMlY5JvQI7a0Wa38MHtDKvM4w_w1q0QjI priority: 102 providerName: ProQuest |
Title | β-catenin mediates monocrotaline-induced pulmonary hypertension via glycolysis in rats |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39044140 https://www.proquest.com/docview/3091289767 https://www.proquest.com/docview/3084030795 https://pubmed.ncbi.nlm.nih.gov/PMC11264393 https://doaj.org/article/b69c8c7a179d4d28adcd2b12b9d23ca6 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB71ISEuiDeBsgoSN2RI7MR2DgixqFWFtBWqWrHiEvmVdqVVUrK7Vbc_ix_Cb2LsTRYWrRCXHGLnNfON55vYngF4zbXRuTOOVBTVkBmek0I6Sbip0Bswq2z4Dzk64cfn2edxPt6BvtxRJ8DZ1tDO15M6b6dvb74vP6DBvw8GL_m7GY6xghL0NsRDMiG3u7CPnkn4igaj7PesgpBhyUeKAzJB2pH2m2i23mPDUYV8_ttI6N9rKf9wTkf34V7HKuOPKxg8gB1XP4Q7o27e_BF8_fmD-KVP9aSOw14RJJgxArDBZ_sUiLUjGJujlm18tZhig2qX8SWGqG1Y4N7U8fVExRfTJcLGpzCJ8T4IndljODs6PPt0TLqSCsRkhZiTKheOiaRS1skiraoqSXSaWiNzLY3mTGvqHK-ynFrFjMlpYTOmqDIM4ygu2BPYq5vaPYNYGMVVheTHly-WupIZxkJOKtQ2mrROI0h78ZWmSzfuq15MyxB2SF6uRF6iyMsg8vI2gjfra65WyTb-2XvotbLu6RNlhxNNe1F2dldqXhhphMJxx2aWSmWNpTqlurCU4SdEcNDrtOzBVzIkURiICi4ieLVuRrvzkymqds3C98HQGAfIIo_g6QoC6zdhRYIsM0sikBvg2HjVzZZ6chlye_sdXcgR2fP_ePALuEsDYAWh7AD25u3CvUSKNNcD2BVjMYD94eHJl9NB-NEwCLaAx9Pht1-QuBR3 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4k2ggJHghKwmdmI7B4R4VVva7WkRe7P8SrvSKln2Adr-Jy78EH4TYydZWIR66zV2HGf8eWY-P2YQesGNNYW3nlQUhiG3vCCl9JJwW4E1YE67uA45POGDz_mncTHeQT_6uzDhWGWvE6Oido0Na-T7DAwbkAPBxZvZVxKyRoXd1T6FRguLI7_-DpRt8frwA4zvS0oPPo7eD0iXVYDYvBRLUhXCM5FW2nlZZlVVpanJMmdlYaQ1nBlDvedVXlCnmbUFLV3ONNWWAZXggkGzV9BVsLtp4HpivOF3mZBp2d_LkXx_Af0VlIARJGGmpOR8y_bFFAH_82v_PZ75l707uIVudo4qftsi6zba8fUddG3YbcXfRV9-_SThNFU9qXG8fgI-KwYhNfDtEFWx9gToPgDH4dlqCgV6vsZnwHrn8cx8U-NvE41Pp2tAYoiKgqEdQOPiHhpdhjzvo926qf1DhIXVXFfgT4WMyNJUMgd65aUGAIGWMFmCsl58ynYRzEMijamKTEZy1YpcgchVFLk6T9CrzTuzNn7HhbXfhVHZ1Ayxt-ODZn6quqmsDC-ttEKDKnO5o1I766jJqCkdZfALCdrrx1R1CmGh_sA3Qc83xTCVw_6Mrn2zCnWAbYPOLYsEPWghsOkJK1NwXPM0QXILHFtd3S6pJ2cxXHi4JAZuJ3t0cb-eoeuD0fBYHR-eHD1GN2jErSCU7aHd5Xzln4DztTRPI-QxUpc8xX4DdDVGiw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%CE%B2-catenin+mediates+monocrotaline-induced+pulmonary+hypertension+via+glycolysis+in+rats&rft.jtitle=BMC+cardiovascular+disorders&rft.au=Meng%2C+Hui&rft.au=Deng%2C+Yan&rft.au=Liao%2C+Juan&rft.au=Wu%2C+Dan-Dan&rft.date=2024-07-23&rft.issn=1471-2261&rft.eissn=1471-2261&rft.volume=24&rft.issue=1&rft.spage=381&rft_id=info:doi/10.1186%2Fs12872-024-04000-z&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2261&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2261&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2261&client=summon |